Subcutaneous Immunoglobulin in Infantile Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report

scientific article published on 01 January 2019

Subcutaneous Immunoglobulin in Infantile Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.4103/JPN.JPN_132_18
P932PMC publication ID6601112
P698PubMed publication ID31316642

P2093author name stringAngela Berardinelli
Silvia Salvatore
Alessandro Salvatoni
Massimo Agosti
Paola Cianci
Alex Moretti
Maddalena Marinoni
P2860cites workIntravenous immunoglobulin: adverse reactions and managementQ37289504
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable conditionQ37714082
Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patientsQ38042583
Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published seriesQ38058926
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide studyQ44954147
New insights in the use of immunoglobulins for the management of immune deficiency (PID) patientsQ45012826
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialQ47419841
Practical aspects of immunoglobulin replacementQ47730138
Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era.Q48527773
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over studyQ48954233
Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.Q53646810
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the PeQ55052893
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathyQ60678381
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathyQ73550695
Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuationsQ80357605
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trialQ80454073
Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in childrenQ82793767
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?Q85464113
P433issue1
P921main subjectdemyelinating polyneuropathyQ18556682
P304page(s)38-41
P577publication date2019-01-01
P1433published inJournal of Pediatric NeurosciencesQ6295723
P1476titleSubcutaneous Immunoglobulin in Infantile Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report
P478volume14